Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wasik

Showing results (141-150 of 278) with videos related to

Pageof 28
Sort By:
Cytokine|January 25, 2003
SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cellsJohannes Lundin Brockdorff, Anders Woetmann, Tomas Mustelin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 16, 2008
Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitroKe Lan, Masanao Murakami, Tathagata Choudhuri, et al.
Molecular Immunology|October 25, 2008
The combination of IL-21 and IFN-alpha boosts STAT3 activation, cytotoxicity and experimental tumor therapyKarsten W Eriksen, Henrik Søndergaard, Anders Woetmann, et al.
Leukemia & Lymphoma|September 1, 1996
Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorderM A Wasik, D C Seldin, J R Butmarc, et al.
Folia Histochemica Et Cytobiologica|June 2, 2000
Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cellsM Majka, J Ratajczak, B Machalinski, et al.
Archives of Dermatology|January 1, 1996
Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implicationsM A Wasik, E C Vonderheid, R D Bigler, et al.
Human Pathology|January 24, 2007
Loss of SHP-1 tyrosine phosphatase expression correlates with the advanced stages of cutaneous T-cell lymphomaAgnieszka Witkiewicz, Puthiyaveettil Raghunath, Agnieszka Wasik, et al.
Journal of Cell Science|February 6, 2014
Sept7b is essential for pronephric function and development of left-right asymmetry in zebrafish embryogenesisSurjya Narayan Dash, Eero Lehtonen, Anita A Wasik, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2020
Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomasDaniel J Landsburg, Alexa Koike, Sunita D Nasta, et al.
Journal of the American Academy of Dermatology|March 5, 1998
Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphomaE C Vonderheid, Q Zhang, S R Lessin, et al.
Pageof 28

Showing results (141-150 of 278) with videos related to

Sort By:
Pageof 28
Cytokine|January 25, 2003
SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cellsJohannes Lundin Brockdorff, Anders Woetmann, Tomas Mustelin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 16, 2008
Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitroKe Lan, Masanao Murakami, Tathagata Choudhuri, et al.
Molecular Immunology|October 25, 2008
The combination of IL-21 and IFN-alpha boosts STAT3 activation, cytotoxicity and experimental tumor therapyKarsten W Eriksen, Henrik Søndergaard, Anders Woetmann, et al.
Leukemia & Lymphoma|September 1, 1996
Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorderM A Wasik, D C Seldin, J R Butmarc, et al.
Folia Histochemica Et Cytobiologica|June 2, 2000
Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cellsM Majka, J Ratajczak, B Machalinski, et al.
Archives of Dermatology|January 1, 1996
Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implicationsM A Wasik, E C Vonderheid, R D Bigler, et al.
Human Pathology|January 24, 2007
Loss of SHP-1 tyrosine phosphatase expression correlates with the advanced stages of cutaneous T-cell lymphomaAgnieszka Witkiewicz, Puthiyaveettil Raghunath, Agnieszka Wasik, et al.
Journal of Cell Science|February 6, 2014
Sept7b is essential for pronephric function and development of left-right asymmetry in zebrafish embryogenesisSurjya Narayan Dash, Eero Lehtonen, Anita A Wasik, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2020
Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomasDaniel J Landsburg, Alexa Koike, Sunita D Nasta, et al.
Journal of the American Academy of Dermatology|March 5, 1998
Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphomaE C Vonderheid, Q Zhang, S R Lessin, et al.
Pageof 28